Streetbeat News

Regulatory

SPY

The USA Core PCE Price Index for March remained steady at 0.3%, aligning with both the estimates and the previous month's figure.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 12:30 pm

SPY

The USA PCE price index for March reported a month-on-month increase of 0.3%, aligning with both the estimated and prior figures.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 12:30 pm

SNY

Sobi announced that the CHMP of the European Medicines Agency has recommended approval of efanesoctocog alfa for haemophilia A treatment. This once-weekly therapy has shown significant improvements in bleed protection and quality of life in clinical studies. Efanesoctocog alfa was approved in the US by the FDA in February 2023, having received Breakthrough Therapy, Fast Track, and Orphan Drug designations.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 12:07 pm

GILD

The FDA has approved an updated label for Gilead Sciences' Biktarvy, including additional data supporting its safety and efficacy for treating pregnant adults with HIV-1. This makes Biktarvy the only second-generation integrase strand transfer inhibitor (INSTI)-based single-tablet regimen with FDA approval for this group. The update is based on Study 5310, which showed maintained viral suppression and no new safety concerns during and post-pregnancy. The DHHS perinatal guidelines now recommend Biktarvy as an alternative regimen for pregnancy and conception.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 12:05 pm

MDT

Medtronic announced FDA approval for its Inceptiv closed-loop spinal cord stimulator, designed to treat chronic pain by automatically adjusting stimulation based on biological signals. This is the first Medtronic SCS device with such a feature, enhancing therapy alignment with daily activities.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 11:58 am

TSLA

At the Orlando Airshow, Tesla's Cybertruck raced against a World War 2-era QuickSilver P-51 Mustang and was defeated, as expected due to the vast difference in top speeds. Despite the loss, Tesla CEO Elon Musk reacted positively, calling it 'cool.' Additionally, Tesla recently recalled 3,878 Cybertruck vehicles due to concerns over unintentional acceleration, with plans to repair or replace the accelerator pedal assembly at no cost. Tesla aims to ramp up Cybertruck production to deliver 250,000 units annually by 2025.

Portfolio Pulse from Anan Ashraf

April 26, 2024 | 11:53 am

VMAR

Vision Marine Technologies announced the filing of a patent for an advanced system communication encryption in its E-Motion powertrain, aimed at enhancing security, ensuring system conformity, and improving the boating experience.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 11:40 am

APLS

Apellis Pharmaceuticals' stock is trading higher following the European Medicines Agency's decision to reset the review of Pegcetacoplan for geographic atrophy to day 180 of the initial assessment.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 11:22 am

APLS

The European Medicines Agency has reset the review of Apellis Pharmaceuticals' intravitreal Pegcetacoplan for Geographic Atrophy to the last phase of the initial assessment, with an anticipated opinion from CHMP by July 2024.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 11:19 am

BMY

Bristol Myers announced that the EMA's CHMP has recommended the approval of Opdivo in combination with cisplatin and gemcitabine for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma. The European Commission will review the recommendation, with a final decision expected in June 2024.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 11:04 am